"ID","biorxiv","published","title","year","journal","doi","author","author_name","author_email","author_address","hypothesis","rationale","MR_design","outcome","outcome_info","outcome_group","outcome_definition","outcome_study","outcome_age_range","outcome_sex","outcome_n_case_current","outcome_n_control_current","outcome_n_case_og","outcome_n_control_og","outcome_n_difference_reason","outcome_health_status","outcome_population","exposure","exposure_definition","exposure_study","exposure_age","exposure_sex","exposure_n_current","exposure_n_og","exposure_n_difference_reason","exposure_health_status","exposure_population","exposure_covariates_model","exposure_genotyping_dataset","exposure_independence","exposure_pleiotropy","exposure_pvalue","exposure_palindrome","exposure_proxy","exposure_HWE","IV_single","IV_multiple","IV_GRS","n_SNP_og","n_SNP_difference_reason","power_calculation","power_calculation_how","MR_method","MR_sensitivity_method1","MR_sensitivity_method2","MR_sensitivity_method3","MR_sensitivity_method4","MR_sensitivity_method5","MR_sensitivity_method_results","IV_strength","analysis_software","analysis_programme","replication_independent","replication_subsetting","multiple_testing","exposure_units","outcome_units","effect_estimate","estimate","se","ci_percent","ci_lower","ci_upper","p","adjustment_method","p_adjusted","limitations_overall","limitations_pleiotropy","limitations_population_stratification","limitations_statistical_power","notes","ID_analysis"
26,"yes","yes","Causal relationships between obesity and the leading causes of death in women and men
",2019,"PLOS Genetics","10.1371/journal.pgen.1008405","Censin","Cecilia M Lindgren","lindgrenpa@bdi.ox.ac.uk","Big Data Institute at the Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, United Kingdom, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom, Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America","Effect of body mass index on multiple disease outcomes","Previous studies have found causal relationships between higher BMI and WHR adjusted for BMI (WHRadjBMI) and type 2 diabetes (T2D) and coronary artery disease (CAD), using a limited number of previously known obesity-associated single nucleotide polymorphisms (SNPs). However, sex-specific relationships are largely unexplored as is the the role that obesity traits play in the leading causes of death beyond these cardiometabolic diseases.","One-sample","DBP","DBP","cardiovascular","The mean of the baseline measurement was used for DBP and 10 mmHg added if blood pressure loweing medications were used 9defined as self reported use of such data-fields 6153 and 6177).","Current study","40-69","both","423507",NA,NA,NA,NA,NA,"European","BMI","BMI","Pulit 2019 BMI European both","18+","both","Not discussed","806834",NA,"Healthy","European","Adjustments were made for baseline age, age2, array type, assessment centre, 10 principalcomponents, and sex if applicable, for all traits when in clinical units and for binary outcomes,and array and 10 principal components if rank inverse normal transformed (where adjustmentfor age, age2, assessment centre, and if applicable sex had already been performed in the rankinverse normal transformation of the residuals)","HRC","We then pruned these SNPs for LD independence, so that not correlated SNPs from different sex-specific analyses would be included, and to obtain a set of the same SNPs for all sex strata. Independent SNPs were selected by taking all the SNPs specified as “index” SNPs in the men, women or combined-sexes analyses and then keeping the SNP with the lowest combined-sexes P-value within each 1 Mb sliding window for BMI, WHR, and WHRadjBMI separately. We later excluded SNPs based on long-distance LD (r2>0.05)","Extensive re-analysis using differnet SNP sets and startification by smoking etc.","5x10-9","Not discussed","Not discussed","P >= 1x10-6",NA,NA,"565","806","Not all exclusions explained. For all GRSs, any SNPs found to be non-biallelic in the UK Biobank were excluded (n=6, rs7798002, rs73646205, rs10828247, rs10892873, rs699370, rs805768), as this would violate the additive assumption. Four SNPs were also excluded as they failed post-imputation quality control (rs11500477, rs144926207, rs547943994, rs9638713). To further ascertain that there was no LD between SNPs in a GRS, we computed the r2 between all pairs of SNPs included in an instrument–for pairs of correlated (r2>0.05) SNPs included in the same instrument, the SNP in each pair with the highest P-value was excluded (rs1025395, rs9302652, rs8189480).","Not discussed",NA,"Wald ratio","MR Egger","Weighted median",NA,NA,NA,"Consistent with main analysis: A few of the GRSs used in the main analysis showed evidence of directional pleiotropy in the MR-Egger intercept test. The MR-Egger point estimates for all these associations were of lower magnitude than the point estimates from the main MR analyses. Despite this, for all the disease outcome MR analyses where one sex had significantly higher estimates than the other the point estimates using the IVW, MR-Egger, and weighted median methods were all higher in the same sex as in the main analysis. This indicates that the sex differences we see are robust using different MR methods to compute causal estimates","Lowest F stat of any GRS was 4,921. We assessed the strengths of associations between the GRSs and their respective obesity trait by computing trait variance explained and the F-statistics. First, we standardized the obesity traits by rank inverse normal transformation of the residuals after regression of the obesity trait on baseline age, age2, assessment centre, and if applicable sex, after any sample quality exclusions. This was done separately for men and women in the sex-specific analyses, but jointly in the combined analyses. For WHRadjBMI, we also adjusted for BMI. We thereafter performed linear regression, adjusting for array type and 10 principal components. Trait variance explained was defined as the increase in adjusted R2 by inclusion of the GRS in the linear regression model. F-statistics were computed using the formula F=((n-k-1)/k)(R^2/〖1-R〗^2 ), where n is the number of observations, k=1 for number of instruments, and R2 the unadjusted R2","R","R package MendelianRandomization","Not discussed","Replicated in white british only subset. Consitent with main analysis","For the obesity trait-disease analyses, the P-value threshold was set at <0.001 (= 0.05/51) for the total of 51 obesity trait-disease combinations investigated in the study. For the obesitytrait-risk factor analyses, the P-value threshold was set at <0.003 (= 0.05/15), for the total of 15obesity trait-risk factor combinations investigated in the study.","SD","Beta","OR","0.27",NA,"95","0.26","0.28000000000000003","<1.0x10-200","Bonferroni for 15 tests","3.3333333333333335E-3","imbalances in the proportion of women and men
in included studies, differential availability of summary-level sex-stratified GWAS data and
the potential for biases to operate differentially between women and men pose additional complexities in deciphering underlying causal effects. It is possible that our genetic instrument for WHRadjBMI might show features of colliderbias whereby SNPs included in the GRS associate with both higher WHR and lower BMI leading to potentially spurious findings. Sensitivity analysis supported main findings. Different SNPs and weightings for SNPs all supported main findings.","Performed extensive re-analysis using different SNP sets which were all consistent with main analysis","Results not generalizeable outside of Europeans. Recent studies have highlighted potential population stratification in both Genetic Investigation of ANthropometric Traits (GIANT) and UKBB. Another study has indicated that GRS distributions can differ slightly between different European populations. We therefore conducted analyses both in all Europeans (self-report of any “white” category) in the main analyses and in a subset of British participants only (in the “White British ancestry subset” as classified by the UK Biobank. The results were highly similar to those performed in all Europeans.","Samll case samples in cancers may have lead to weak power. In women, the effects of WHR were directionally consistent with harm, but the estimates were imprecise, probably reflecting insufficient powerin the sex-stratified analysis.",NA,480
26,"yes","yes","Causal relationships between obesity and the leading causes of death in women and men
",2019,"PLOS Genetics","10.1371/journal.pgen.1008405","Censin","Cecilia M Lindgren","lindgrenpa@bdi.ox.ac.uk","Big Data Institute at the Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, United Kingdom, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom, Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America","Effect of body mass index on multiple disease outcomes","Previous studies have found causal relationships between higher BMI and WHR adjusted for BMI (WHRadjBMI) and type 2 diabetes (T2D) and coronary artery disease (CAD), using a limited number of previously known obesity-associated single nucleotide polymorphisms (SNPs). However, sex-specific relationships are largely unexplored as is the the role that obesity traits play in the leading causes of death beyond these cardiometabolic diseases.","One-sample","DBP","DBP","cardiovascular","The mean of the baseline measurement was used for DBP and 10 mmHg added if blood pressure loweing medications were used 9defined as self reported use of such data-fields 6153 and 6177).","Current study","40-69","male","195041",NA,NA,NA,NA,NA,"European","BMI","BMI","Pulit 2019 BMI European male","18+","male","Not discussed","374756",NA,"Healthy","European","Adjustments were made for baseline age, age2, array type, assessment centre, 10 principalcomponents, and sex if applicable, for all traits when in clinical units and for binary outcomes,and array and 10 principal components if rank inverse normal transformed (where adjustmentfor age, age2, assessment centre, and if applicable sex had already been performed in the rankinverse normal transformation of the residuals)","HRC","We then pruned these SNPs for LD independence, so that not correlated SNPs from different sex-specific analyses would be included, and to obtain a set of the same SNPs for all sex strata. Independent SNPs were selected by taking all the SNPs specified as “index” SNPs in the men, women or combined-sexes analyses and then keeping the SNP with the lowest combined-sexes P-value within each 1 Mb sliding window for BMI, WHR, and WHRadjBMI separately. We later excluded SNPs based on long-distance LD (r2>0.05)","Extensive re-analysis using differnet SNP sets and startification by smoking etc.","5x10-9","Not discussed","Not discussed","P >= 1x10-6",NA,NA,"220","243","Not all exclusions explained. For all GRSs, any SNPs found to be non-biallelic in the UK Biobank were excluded (n=6, rs7798002, rs73646205, rs10828247, rs10892873, rs699370, rs805768), as this would violate the additive assumption. Four SNPs were also excluded as they failed post-imputation quality control (rs11500477, rs144926207, rs547943994, rs9638713). To further ascertain that there was no LD between SNPs in a GRS, we computed the r2 between all pairs of SNPs included in an instrument–for pairs of correlated (r2>0.05) SNPs included in the same instrument, the SNP in each pair with the highest P-value was excluded (rs1025395, rs9302652, rs8189480).","Not discussed",NA,"Wald ratio","MR Egger","Weighted median",NA,NA,NA,"Consistent with main analysis: A few of the GRSs used in the main analysis showed evidence of directional pleiotropy in the MR-Egger intercept test. The MR-Egger point estimates for all these associations were of lower magnitude than the point estimates from the main MR analyses. Despite this, for all the disease outcome MR analyses where one sex had significantly higher estimates than the other the point estimates using the IVW, MR-Egger, and weighted median methods were all higher in the same sex as in the main analysis. This indicates that the sex differences we see are robust using different MR methods to compute causal estimates","Lowest F stat of any GRS was 4,921. We assessed the strengths of associations between the GRSs and their respective obesity trait by computing trait variance explained and the F-statistics. First, we standardized the obesity traits by rank inverse normal transformation of the residuals after regression of the obesity trait on baseline age, age2, assessment centre, and if applicable sex, after any sample quality exclusions. This was done separately for men and women in the sex-specific analyses, but jointly in the combined analyses. For WHRadjBMI, we also adjusted for BMI. We thereafter performed linear regression, adjusting for array type and 10 principal components. Trait variance explained was defined as the increase in adjusted R2 by inclusion of the GRS in the linear regression model. F-statistics were computed using the formula F=((n-k-1)/k)(R^2/〖1-R〗^2 ), where n is the number of observations, k=1 for number of instruments, and R2 the unadjusted R2","R","R package MendelianRandomization","Not discussed","Replicated in white british only subset. Consitent with main analysis","For the obesity trait-disease analyses, the P-value threshold was set at <0.001 (= 0.05/51) for the total of 51 obesity trait-disease combinations investigated in the study. For the obesitytrait-risk factor analyses, the P-value threshold was set at <0.003 (= 0.05/15), for the total of 15obesity trait-risk factor combinations investigated in the study.","SD","Beta","OR","0.24",NA,"95","0.22","0.26","1.6x10-140","Bonferroni for 15 tests","3.3333333333333335E-3","imbalances in the proportion of women and men
in included studies, differential availability of summary-level sex-stratified GWAS data and
the potential for biases to operate differentially between women and men pose additional complexities in deciphering underlying causal effects. It is possible that our genetic instrument for WHRadjBMI might show features of colliderbias whereby SNPs included in the GRS associate with both higher WHR and lower BMI leading to potentially spurious findings. Sensitivity analysis supported main findings. Different SNPs and weightings for SNPs all supported main findings.","Performed extensive re-analysis using different SNP sets which were all consistent with main analysis","Results not generalizeable outside of Europeans. Recent studies have highlighted potential population stratification in both Genetic Investigation of ANthropometric Traits (GIANT) and UKBB. Another study has indicated that GRS distributions can differ slightly between different European populations. We therefore conducted analyses both in all Europeans (self-report of any “white” category) in the main analyses and in a subset of British participants only (in the “White British ancestry subset” as classified by the UK Biobank. The results were highly similar to those performed in all Europeans.","Samll case samples in cancers may have lead to weak power. In women, the effects of WHR were directionally consistent with harm, but the estimates were imprecise, probably reflecting insufficient powerin the sex-stratified analysis.",NA,481
26,"yes","yes","Causal relationships between obesity and the leading causes of death in women and men
",2019,"PLOS Genetics","10.1371/journal.pgen.1008405","Censin","Cecilia M Lindgren","lindgrenpa@bdi.ox.ac.uk","Big Data Institute at the Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, United Kingdom, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom, Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America","Effect of body mass index on multiple disease outcomes","Previous studies have found causal relationships between higher BMI and WHR adjusted for BMI (WHRadjBMI) and type 2 diabetes (T2D) and coronary artery disease (CAD), using a limited number of previously known obesity-associated single nucleotide polymorphisms (SNPs). However, sex-specific relationships are largely unexplored as is the the role that obesity traits play in the leading causes of death beyond these cardiometabolic diseases.","One-sample","DBP","DBP","cardiovascular","The mean of the baseline measurement was used for DBP and 10 mmHg added if blood pressure loweing medications were used 9defined as self reported use of such data-fields 6153 and 6177).","Current study","40-69","female","228466",NA,NA,NA,NA,NA,"European","BMI","BMI","Pulit 2019 BMI European female","18+","female","Not discussed","434794",NA,"Healthy","European","Adjustments were made for baseline age, age2, array type, assessment centre, 10 principalcomponents, and sex if applicable, for all traits when in clinical units and for binary outcomes,and array and 10 principal components if rank inverse normal transformed (where adjustmentfor age, age2, assessment centre, and if applicable sex had already been performed in the rankinverse normal transformation of the residuals)","HRC","We then pruned these SNPs for LD independence, so that not correlated SNPs from different sex-specific analyses would be included, and to obtain a set of the same SNPs for all sex strata. Independent SNPs were selected by taking all the SNPs specified as “index” SNPs in the men, women or combined-sexes analyses and then keeping the SNP with the lowest combined-sexes P-value within each 1 Mb sliding window for BMI, WHR, and WHRadjBMI separately. We later excluded SNPs based on long-distance LD (r2>0.05)","Extensive re-analysis using differnet SNP sets and startification by smoking etc.","5x10-9","Not discussed","Not discussed","P >= 1x10-6",NA,NA,"278","306","Not all exclusions explained. For all GRSs, any SNPs found to be non-biallelic in the UK Biobank were excluded (n=6, rs7798002, rs73646205, rs10828247, rs10892873, rs699370, rs805768), as this would violate the additive assumption. Four SNPs were also excluded as they failed post-imputation quality control (rs11500477, rs144926207, rs547943994, rs9638713). To further ascertain that there was no LD between SNPs in a GRS, we computed the r2 between all pairs of SNPs included in an instrument–for pairs of correlated (r2>0.05) SNPs included in the same instrument, the SNP in each pair with the highest P-value was excluded (rs1025395, rs9302652, rs8189480).","Not discussed",NA,"Wald ratio","MR Egger","Weighted median",NA,NA,NA,"Consistent with main analysis: A few of the GRSs used in the main analysis showed evidence of directional pleiotropy in the MR-Egger intercept test. The MR-Egger point estimates for all these associations were of lower magnitude than the point estimates from the main MR analyses. Despite this, for all the disease outcome MR analyses where one sex had significantly higher estimates than the other the point estimates using the IVW, MR-Egger, and weighted median methods were all higher in the same sex as in the main analysis. This indicates that the sex differences we see are robust using different MR methods to compute causal estimates","Lowest F stat of any GRS was 4,921. We assessed the strengths of associations between the GRSs and their respective obesity trait by computing trait variance explained and the F-statistics. First, we standardized the obesity traits by rank inverse normal transformation of the residuals after regression of the obesity trait on baseline age, age2, assessment centre, and if applicable sex, after any sample quality exclusions. This was done separately for men and women in the sex-specific analyses, but jointly in the combined analyses. For WHRadjBMI, we also adjusted for BMI. We thereafter performed linear regression, adjusting for array type and 10 principal components. Trait variance explained was defined as the increase in adjusted R2 by inclusion of the GRS in the linear regression model. F-statistics were computed using the formula F=((n-k-1)/k)(R^2/〖1-R〗^2 ), where n is the number of observations, k=1 for number of instruments, and R2 the unadjusted R2","R","R package MendelianRandomization","Not discussed","Replicated in white british only subset. Consitent with main analysis","For the obesity trait-disease analyses, the P-value threshold was set at <0.001 (= 0.05/51) for the total of 51 obesity trait-disease combinations investigated in the study. For the obesitytrait-risk factor analyses, the P-value threshold was set at <0.003 (= 0.05/15), for the total of 15obesity trait-risk factor combinations investigated in the study.","SD","Beta","OR","0.3",NA,"95","0.28000000000000003","0.31","<1.0x10-200","Bonferroni for 15 tests","3.3333333333333335E-3","imbalances in the proportion of women and men
in included studies, differential availability of summary-level sex-stratified GWAS data and
the potential for biases to operate differentially between women and men pose additional complexities in deciphering underlying causal effects. It is possible that our genetic instrument for WHRadjBMI might show features of colliderbias whereby SNPs included in the GRS associate with both higher WHR and lower BMI leading to potentially spurious findings. Sensitivity analysis supported main findings. Different SNPs and weightings for SNPs all supported main findings.","Performed extensive re-analysis using different SNP sets which were all consistent with main analysis","Results not generalizeable outside of Europeans. Recent studies have highlighted potential population stratification in both Genetic Investigation of ANthropometric Traits (GIANT) and UKBB. Another study has indicated that GRS distributions can differ slightly between different European populations. We therefore conducted analyses both in all Europeans (self-report of any “white” category) in the main analyses and in a subset of British participants only (in the “White British ancestry subset” as classified by the UK Biobank. The results were highly similar to those performed in all Europeans.","Samll case samples in cancers may have lead to weak power. In women, the effects of WHR were directionally consistent with harm, but the estimates were imprecise, probably reflecting insufficient powerin the sex-stratified analysis.",NA,482
48,"no","yes","The Role of Adiposity in Cardiometabolic Traits: A
Mendelian Randomization Analysis",2013,"PLOS Medicine","10.1371/journal.pmed.1001474","Fall","Erik Ingelsson","erik.ingelsson@medsci.uu.se","Molecular Epidemiology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden","Effect of body mass index on cardiometabolic traits","The association between adiposity and cardiometabolic traits is well known from epidemiological studies. Whilst the causal relationship is clear for some of these traits, for others it is not.","one-sample meta-analysis","DBP","DBP","cardiovascular","Not discussed","Current study","18+","Both","130380",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Current study","18+","Both","130380",NA,NA,"Healthy","European","Age, Sex","Whenever rs9939609 was not genotyped directly, we used either (i) the HapMap II CEU (European) reference panel–imputed genetic information from genome-wide association studies (http://hapmap.ncbi.nlm.nih.gov/downloads/genotypes/2008-10_phaseII/) for rs9939609 (n = 5) or (ii) genotype information from a predefined list of proxies that are in high linkage disequilibrium (LD) with rs9939609 (n = 10, r2>0.9; Table S3)",NA,"Not discussed","Not discussed",NA,"R2 > 0.9","p>0.0001","FTO (rs9939609)",NA,NA,NA,NA,"No",NA,"Inverse variance weighted (multiplicative random effects)","Not discussed",NA,NA,NA,NA,"Observational estimates were similar","Not discussed","Varied by cohort but  at least one cohort used PLINK, R, SPSS, STATA","Not discussed","Not discussed","Not discussed","No","kg/m2","mm Hg","beta","0.49",NA,"95","0.187","0.79300000000000004","2E-3","None",NA,"The limitations of our study are tied to the validity of the assumptions underlying causal interpretation within MR studies.","the precise mechanism of the FTO polymorphisms is still unclear, and potential pleiotropy cannot completely be ruled out","all studies included only individuals of European ancestry. Hence, bias from population stratification is deemed unlikely","Post hoc power calculation showed that for the binary traits with non-significant IVs (CHD, ischemic stroke, and all-cause stroke), we had an 80% chance of detecting an IV estimator odds ratio (OR) of 1.08–1.09/BMI unit or higher, and a 95% chance of detecting an OR of 1.13–1.15/BMI unit or higher.",NA,756
49,"no","yes","Age- and Sex-Specific Causal Effects
of Adiposity on Cardiovascular
Risk Factors",2015,"Diabetes","10.2337/db14-0988","Fall","Erik Ingelsson","erik.ingelsson@medsci.uu.se","Molecular Epidemiology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden","Effect of body mass index on cardiometabolic traits","Observational studies have reported different effects of adiposity on cardiovascular risk factors across age and sex. Since cardiovascular risk factors are enriched in obese individuals, it has not been easy to dissect the effects of adiposity from those of other risk factors.","one-sample meta-analysis","DBP","DBP","cardiovascular","Varied by cohort: where observed values were increased with 15 mmHg for systolic blood pressure and 10 mmHg for diastolic blood pressure in case of reported hypertension medication","Current study","<55","Both","35518",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Speliotes 2010 BMI Europeans both","<55","both","35518","249796","One sample where they took exposure SNPs from other GWAS","Healthy","European","Sex","Directly genotyped, not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Yes, directly genotyped proxy SNPs from a predefined list of variants that are in high linkage disequilibrium (LD) with lead SNPs were used","p>0.0001",NA,NA,"32","32",NA,"No",NA,"Inverse variance weighted (fixed effects)","Not discussed",NA,NA,NA,NA,NA,"F-statistic = 484","R 3.0.0","rmeta for random effect meta-analysis, unclear for calculating estimates","Not discussed","Not discussed","Benjamini and Hochberg (24) procedure implemented in the STATA multproc procedure to correct the level of significance to a 5% false discovery rate (FDR).","SD","SD","beta","0.21",NA,"95","0.09","0.33","8.0×10−4","5% FDR","2.1999999999999999E-2","The limitations are mainly related to the validity of the assumptions underlying causal interpretation within Mendelian randomization studies","Possible violations of the first and the third assumptions include population stratification, pleiotropic effects, canalization, epigenetic effects, and the presence of genes associated with confounders and outcomes in LD with the genetic variants used.","all studies included only individuals of European ancestry. Hence, bias from population stratification is deemed unlikely.","No formal analysis, but they do qualitatively talk about the power, e.g.: ""The sample sizes in IV analyses varied with phenotype and strata from 2,077 individuals (age ,55 years, 2-h post-OGTT glucose levels) to 67,553 individuals (nonstratified analysis, systolic blood pressure), yielding larger SEs in the smaller groups, and lower statistical power to detect causal effects and differences between strata.""","Also present results straitified by age and sex",766
49,"no","yes","Age- and Sex-Specific Causal Effects
of Adiposity on Cardiovascular
Risk Factors",2015,"Diabetes","10.2337/db14-0988","Fall","Erik Ingelsson","erik.ingelsson@medsci.uu.se","Molecular Epidemiology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden","Effect of body mass index on cardiometabolic traits","Observational studies have reported different effects of adiposity on cardiovascular risk factors across age and sex. Since cardiovascular risk factors are enriched in obese individuals, it has not been easy to dissect the effects of adiposity from those of other risk factors.","one-sample meta-analysis","DBP","DBP","cardiovascular","Varied by cohort: where observed values were increased with 15 mmHg for systolic blood pressure and 10 mmHg for diastolic blood pressure in case of reported hypertension medication","Current study",">55","Both","32596",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Speliotes 2010 BMI Europeans both",">55","both","32596","249796","One sample where they took exposure SNPs from other GWAS","Healthy","European","Sex","Directly genotyped, not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Yes, directly genotyped proxy SNPs from a predefined list of variants that are in high linkage disequilibrium (LD) with lead SNPs were used","p>0.0001",NA,NA,"32","32",NA,"No",NA,"Inverse variance weighted (fixed effects)","Not discussed",NA,NA,NA,NA,NA,"F-statistic = 484","R 3.0.0","rmeta for random effect meta-analysis, unclear for calculating estimates","Not discussed","Not discussed","Benjamini and Hochberg (24) procedure implemented in the STATA multproc procedure to correct the level of significance to a 5% false discovery rate (FDR).","SD","SD","beta","0.01",NA,"95","-0.16","0.18","0.01","5% FDR","2.1999999999999999E-2","The limitations are mainly related to the validity of the assumptions underlying causal interpretation within Mendelian randomization studies","Possible violations of the first and the third assumptions include population stratification, pleiotropic effects, canalization, epigenetic effects, and the presence of genes associated with confounders and outcomes in LD with the genetic variants used.","all studies included only individuals of European ancestry. Hence, bias from population stratification is deemed unlikely.","No formal analysis, but they do qualitatively talk about the power, e.g.: ""The sample sizes in IV analyses varied with phenotype and strata from 2,077 individuals (age ,55 years, 2-h post-OGTT glucose levels) to 67,553 individuals (nonstratified analysis, systolic blood pressure), yielding larger SEs in the smaller groups, and lower statistical power to detect causal effects and differences between strata.""","Also present results straitified by age and sex",780
49,"no","yes","Age- and Sex-Specific Causal Effects
of Adiposity on Cardiovascular
Risk Factors",2015,"Diabetes","10.2337/db14-0988","Fall","Erik Ingelsson","erik.ingelsson@medsci.uu.se","Molecular Epidemiology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden","Effect of body mass index on cardiometabolic traits","Observational studies have reported different effects of adiposity on cardiovascular risk factors across age and sex. Since cardiovascular risk factors are enriched in obese individuals, it has not been easy to dissect the effects of adiposity from those of other risk factors.","one-sample meta-analysis","DBP","DBP","cardiovascular","Varied by cohort: where observed values were increased with 15 mmHg for systolic blood pressure and 10 mmHg for diastolic blood pressure in case of reported hypertension medication","Current study","18+","Women","34333",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Speliotes 2010 BMI Europeans both","18+","both","34333","249796","One sample where they took exposure SNPs from other GWAS","Healthy","European","Age","Directly genotyped, not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Yes, directly genotyped proxy SNPs from a predefined list of variants that are in high linkage disequilibrium (LD) with lead SNPs were used","p>0.0001",NA,NA,"32","32",NA,"No",NA,"Inverse variance weighted (fixed effects)","Not discussed",NA,NA,NA,NA,NA,"F-statistic = 484","R 3.0.0","rmeta for random effect meta-analysis, unclear for calculating estimates","Not discussed","Not discussed","Benjamini and Hochberg (24) procedure implemented in the STATA multproc procedure to correct the level of significance to a 5% false discovery rate (FDR).","SD","SD","beta","7.0000000000000007E-2",NA,"95","−0.04","0.18","0.24","5% FDR","2.1999999999999999E-2","The limitations are mainly related to the validity of the assumptions underlying causal interpretation within Mendelian randomization studies","Possible violations of the first and the third assumptions include population stratification, pleiotropic effects, canalization, epigenetic effects, and the presence of genes associated with confounders and outcomes in LD with the genetic variants used.","all studies included only individuals of European ancestry. Hence, bias from population stratification is deemed unlikely.","No formal analysis, but they do qualitatively talk about the power, e.g.: ""The sample sizes in IV analyses varied with phenotype and strata from 2,077 individuals (age ,55 years, 2-h post-OGTT glucose levels) to 67,553 individuals (nonstratified analysis, systolic blood pressure), yielding larger SEs in the smaller groups, and lower statistical power to detect causal effects and differences between strata.""","Also present results straitified by age and sex",794
49,"no","yes","Age- and Sex-Specific Causal Effects
of Adiposity on Cardiovascular
Risk Factors",2015,"Diabetes","10.2337/db14-0988","Fall","Erik Ingelsson","erik.ingelsson@medsci.uu.se","Molecular Epidemiology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden","Effect of body mass index on cardiometabolic traits","Observational studies have reported different effects of adiposity on cardiovascular risk factors across age and sex. Since cardiovascular risk factors are enriched in obese individuals, it has not been easy to dissect the effects of adiposity from those of other risk factors.","one-sample meta-analysis","DBP","DBP","cardiovascular","Varied by cohort: where observed values were increased with 15 mmHg for systolic blood pressure and 10 mmHg for diastolic blood pressure in case of reported hypertension medication","Current study","18+","Men","32664",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Speliotes 2010 BMI Europeans both","18+","both","32664","249796","One sample where they took exposure SNPs from other GWAS","Healthy","European","Age","Directly genotyped, not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Yes, directly genotyped proxy SNPs from a predefined list of variants that are in high linkage disequilibrium (LD) with lead SNPs were used","p>0.0001",NA,NA,"32","32",NA,"No",NA,"Inverse variance weighted (fixed effects)","Not discussed",NA,NA,NA,NA,NA,"F-statistic = 484","R 3.0.0","rmeta for random effect meta-analysis, unclear for calculating estimates","Not discussed","Not discussed","Benjamini and Hochberg (24) procedure implemented in the STATA multproc procedure to correct the level of significance to a 5% false discovery rate (FDR).","SD","SD","beta","0.23",NA,"95","0.06","0.4","8.0000000000000002E-3","5% FDR","2.1999999999999999E-2","The limitations are mainly related to the validity of the assumptions underlying causal interpretation within Mendelian randomization studies","Possible violations of the first and the third assumptions include population stratification, pleiotropic effects, canalization, epigenetic effects, and the presence of genes associated with confounders and outcomes in LD with the genetic variants used.","all studies included only individuals of European ancestry. Hence, bias from population stratification is deemed unlikely.","No formal analysis, but they do qualitatively talk about the power, e.g.: ""The sample sizes in IV analyses varied with phenotype and strata from 2,077 individuals (age ,55 years, 2-h post-OGTT glucose levels) to 67,553 individuals (nonstratified analysis, systolic blood pressure), yielding larger SEs in the smaller groups, and lower statistical power to detect causal effects and differences between strata.""","Also present results straitified by age and sex",808
49,"no","yes","Age- and Sex-Specific Causal Effects
of Adiposity on Cardiovascular
Risk Factors",2015,"Diabetes","10.2337/db14-0988","Fall","Erik Ingelsson","erik.ingelsson@medsci.uu.se","Molecular Epidemiology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden","Effect of body mass index on cardiometabolic traits","Observational studies have reported different effects of adiposity on cardiovascular risk factors across age and sex. Since cardiovascular risk factors are enriched in obese individuals, it has not been easy to dissect the effects of adiposity from those of other risk factors.","one-sample meta-analysis","DBP","DBP","cardiovascular","Varied by cohort: where observed values were increased with 15 mmHg for systolic blood pressure and 10 mmHg for diastolic blood pressure in case of reported hypertension medication","Current study","18+","Both","66997",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Speliotes 2010 BMI Europeans both","18+","both","66997","249796","One sample where they took exposure SNPs from other GWAS","Healthy","European","Age, Sex","Directly genotyped, not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Yes, directly genotyped proxy SNPs from a predefined list of variants that are in high linkage disequilibrium (LD) with lead SNPs were used","p>0.0001",NA,NA,"32","32",NA,"No",NA,"Inverse variance weighted (fixed effects)","Not discussed",NA,NA,NA,NA,NA,"F-statistic = 484","R 3.0.0","rmeta for random effect meta-analysis, unclear for calculating estimates","Not discussed","Not discussed","Benjamini and Hochberg (24) procedure implemented in the STATA multproc procedure to correct the level of significance to a 5% false discovery rate (FDR).","SD","SD","beta","0.15",NA,"95","0.03","0.26","0.01","5% FDR","2.1999999999999999E-2","The limitations are mainly related to the validity of the assumptions underlying causal interpretation within Mendelian randomization studies","Possible violations of the first and the third assumptions include population stratification, pleiotropic effects, canalization, epigenetic effects, and the presence of genes associated with confounders and outcomes in LD with the genetic variants used.","all studies included only individuals of European ancestry. Hence, bias from population stratification is deemed unlikely.","No formal analysis, but they do qualitatively talk about the power, e.g.: ""The sample sizes in IV analyses varied with phenotype and strata from 2,077 individuals (age ,55 years, 2-h post-OGTT glucose levels) to 67,553 individuals (nonstratified analysis, systolic blood pressure), yielding larger SEs in the smaller groups, and lower statistical power to detect causal effects and differences between strata.""","Also present results straitified by age and sex",822
90,"no","yes","Association of Body Mass Index With Cardiometabolic Disease in the UK Biobank",2016,"JAMA Cardiology","10.1001/jamacardio.2016.5804","Lyall","Donald M. Lyall","donald.lyall@glasgow.ac.uk","Institute of Health and Wellbeing, University of Glasgow, 1 Lilybank Gardens, Glasgow G12 8RZ, Scotland","Effect of body mass index on cardiometabolic diseases/traits","Higher body mass index (BMI) is a risk factor for cardiometabolic disease; however, the underlying causal associations remain unclear.","One-sample","DBP","DBP","cardiovascular","Blood pressure and pulse rate were assessed using digital blood pressure monitors (HEM-7015IT; Omron Healthcare Inc). We used the first reading because it had the largest sample size.","Current study","37-73","both","111638",NA,NA,NA,NA,"Healthy - levels of DBP","White Europeans","BMI","BMI","Locke 2015 BMI All ancestries both","Age range in Locke et al paper is 11-108","both","339224","339224",NA,"Healthy","Europeans","assessment centre, age, sex, genetic batch effect, array and stratification with 10 principal components","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Yes",NA,NA,"93","97","95 genotyped and 2 not in HWE","Not discussed",NA,"Two-stage-least-squares","MR Egger",NA,NA,NA,NA,"Consistent with main analysis: Note that they said that they visually looked for outliers on the snp-exposure/snp-outcome scatter plot to see if there were any outliers. They said there was one for each of t2d and both blood pressure. However ""results were unchanged when these outliers were removed and, for simplicity, we report estimates derived using all 93 SNPs""","F-statistic","Stata version 13","ivreg2","Not discussed","Not discussed","Yes - the authors stated ""All statistical tests were 2-sided and P<0.01 was chosen as we had multiple outcomes; formal correction for type 1 error can be overly conservative when testing intercorrelated outcomes"" but they don't show any correlations between outcomes or justify the choice of 0.01 any further than that statement","SD","mmHg","beta","1.1200000000000001",NA,"95","0.76","1.69","2.5x10-07","Not fully explained",NA,"We found a small but significant correlation between the PGR score and higher rates of smoking, alcohol intake, and Townsend deprivation scores and thus made additional adjustments for these factors in our analyses, which did notalter the estimates we obtained.","Whether these associations represent vertical or horizontal pleiotropy remains unknown. The present sample also lacks data on a complete repertoire of potential mediators, such as lipid traits and glucose levels; these data will be available in the full UK Biobank in the next few years.","There may be a degree of selection bias in the sense that less physically and cognitively impaired individuals responded to theUKBiobank invitation and attended the assessment. The UK Biobank cohort is representative of the UK population in terms of some characteristics, such as age, sex, ethnicity, and deprivation, but not necessarily all (eg,someparticipants are less likely tosmoke and drink alcohol regularly).","Because MR-Egger is inherently more conservative, potentially meaningful causal associations might not be identified (type II error). Furthermore, this approach may be inadequately powered to detect pleiotropy when it is present.","Note: it's unclear how many individuals were used as controls, as the authors only state the number of cases and not the number of controls or not how many individuals overlapped between the four binary outcomes (i.e., stroke, CHD, hypertension and T2D). One note is that they state that they used 97 variants from the study of 339224 individuals of EUROPEAN descent. So actually unclear as to whether they used the European adults one or the all ancestries results. Note that the authors also did an adjusted model for townsend deprivation score, smoking and alcohol.  The results didn't really change when adding these (the betas attenuated slightly with some and inflated in others but confidence intervals all overlapped).",1352
135,"yes","yes","Semiparametric methods for estimation of a nonlinear exposure-outcome relationship using instrumental variables with application to Mendelian randomization",2017,"International Genetic Epidemiology Society","10.1002/gepi.22041","Staley","Stephen Burgess","sb452@medschl.cam.ac.uk","Strangeways Research Laboratory, Department of Public Health and Primary Care, Cardiovascular Epidemiology Unit, University of Cambridge, Wort's Causeway, Cambridge CB1 8RN, UK.","Method paper: Effect of body mass index on systolic and diastolic blood pressure","Most IV methods assume that the function relating the exposure to the expected value of the outcome (the exposure-outcome relationship) is linear.However, in practice, this assumption may not hold","One-sample","DBP","DBP","cardiovascular","Not discussed","Current study","40-79","both","133687",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Locke 2015 BMI All ancestries both","40-79","both","133687","339224","One-sample","Healthy","European","age, sex, and center","European samples from 1KG","Not discussed","Not discussed","5x10-8","Not discussed","A proxy variant (rs751414; 𝑟2 = 0.99) was used instead of rs2033529","Not discussed",NA,NA,"97","97",NA,"Not discussed",NA,"Two-stage-least-squares",NA,NA,NA,NA,NA,NA,"r2","R","Not discussed","Not discussed","Not discussed","Not discussed","kg/m2","mmHg","Beta","0.433",NA,"95","0.338","0.528",NA,"None",NA,"Limitations focussed on the method in development","Not discussed","Not discussed","Not discussed",NA,1646
144,"no","yes","Does Greater Adiposity Increase Blood Pressure and Hypertension Risk?",2009,"Hypertension","10.1161/HYPERTENSIONAHA.109.130005","Timpson","Børge G. Nordestgaard,","brno@heh.regionh.dk","Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730 Herlev, Denmark","Effect of body mass index on systolic and diastolic blood pressure","Current observational data suggest that body mass index may have a causal role in the etiology of hypertension, but this may be influenced by confounding and reverse causation","One-sample","DBP","DBP","cardiovascular","Diastolic blood pressure in mm Hg","Current study","median age = 57.6","both","37027",NA,NA,NA,NA,"Healthy","Danish","BMI","BMI","Current study",NA,"both","36867","36867",NA,"Healthy","Danish","Age, sex, and height","Sequence data",NA,"Not discussed","5x10-8",NA,NA,"Not discussed","2",NA,NA,NA,NA,"Not discussed",NA,"Generalised method of moments (GMM)",NA,NA,NA,NA,NA,"Genotyped rare FTO and MC4R variants","Linear regression with phenotype","Stata","Not discussed","Not discussed","Not discussed","Not discussed","kg/m2","mm Hg","Change in mm Hg per increase in 10% BMI","1.79",NA,"95","0.68","2.9","2E-3",NA,NA,"the possible effects of canalization are lessened because of both the apparent lack of effect of the FTO locus on adiposity in early life and the concordance of MC4R-derived results with those of FTO as an instrument for adiposity","A further possible limitation of the approach taken in this work relates to the possible existence of pleiotropy concerning the genetic variation used as a proxy measure for BMI.35 Recent work concentrating on rare variation at the MC4R locus has suggested that there may be a BMI and insulin-independent effect on BP, and, as such, it may have the potential to introduce error to the inference taken from instrumental variable analysis.36 However, analyses here suggest an attenuation of the expected association between variation of the MC4R locus and BP (Table 2), suggesting that MC4R variation retains a BMI-specific BP effect (as seen for FTO).","because of the nature of this population cohort, both population stratification and power are unlikely to have considerable impact","because of the nature of this population cohort, both population stratification and power are unlikely to have considerable impact",NA,1706
154,"yes","yes","Assessing the Causal Role of Body Mass Index on Cardiovascular Health in Young Adults",2018,"Circulation","10.1161/CIRCULATIONAHA.117.033278","Wade","Kaitlin H. Wade","Kaitlin.Wade@bristol.ac.uk","Oakfield House, Oakfield Grove, Bristol BS8 2BN, United Kingdom","Effect of body mass index on cardiometabolic diseases","the nature of these relationships has been assessed predominantly in populations of adults, and no large studies have explicitly assessed the causal impact of BMI on detailed cardiovascular phenotypes in early life, where risk may emerge","One-sample","DBP","DBP","cardiovascular","Sitting BP and heart rate were measured in both arms with an Omron 705 IT oscillometric BP monitor in accordance with European Society of Hypertension guidelines.1 The average of the final two of three readings was used and the arm with the greatest number of valid observations was used for analyses","Current study","17-18","both","3108",NA,NA,NA,NA,"Healthy","British","BMI","BMI","Locke 2015 BMI All ancestries both","17-18","both","3108","339224","One-sample","Healthy","British","None","Illumina HumanHap550 quad genome-wide SNP genotyping platform","Not discussed","To investigate the validity of the weighted GRS as an IV, the MREgger approach was used to detect and accommodate violations of the MR assumptions. As a sensitivity analysis, 3 variants were removed from the GRS that were suggested they were pleiotropic.","5x10-8","Not discussed","Not discussed","P<5x10-7",NA,NA,"97","97",NA,"Not discussed",NA,"Two-stage-least-squares","MR Egger","Weighted median","Re-ran analyses after excluding potentially pleiotropic snps",NA,NA,"Consistent with main analysis","F-statistic","Stata","Not discussed","Not discussed","Not discussed","Not discussed","kg/m2","mmHg","beta","0.29",NA,"95","2e-04","0.59","0.05",NA,NA,"In addition, it is possible that some of the differences in effect size of BMI on cardiovascular outcomes (for example, carotid-femoral PWV) between ages may relate to either the difference in age at which the analyses were undertaken or phenotyping methods used at these ages. Finally, in all analyses, we only included participants with complete data on all variables used in the specific model (ie, complete data on BMI, outcome and all confounders in multivariable analyses and on genetic instruments, BMI and outcome in Mendelian randomization). This assumes that missing data are missing at random. The similarity in characteristics between those with complete data and those with any missing data suggested that this assumption is unlikely to be violated.","Although we aimed to make best use of all available data, our main analyses included the use of an aggregate GRS comprising all 97 SNPs associated with BMI, which may increase the possibility of horizontal pleiotropy.","Not discussed","Given the small range of some of the cardiovascular outcomes (for example, cIMT) in these young individuals and the potentially small effect size of BMI, power to detect such small effect sizes in this context may be limited.",NA,1778
170,"no","yes","Metabolic Signatures of Adiposity in Young Adults: Mendelian Randomization Analysis and Effects of Weight Change",2014,"PLOS Medicine","10.1371/journal.pmed.1001765","Wurtz","Peter Wurtz","peter.wurtz@computationalmedicine.fi","Computational Medicine, Institute of Health Sciences, University of Oulu, Oulu, Finland","Effect of body mass index on NMR metabolites","The pattern of metabolic aberrations observed cross-sectionally was compared to the causal effect estimates and longitudinal associations in order to summa- rize the influence of adiposity on the metabolic risk profile, and to clarify the metabolic consequences of weight change in early adulthood.","One-sample","DBP","DBP","cardiovascular","mmHg","Current study","16-39","both","12627",NA,NA,NA,NA,"healthy","European ancestry","BMI","BMI","Speliotes 2010 BMI Europeans both","16-39","both","12627","249796","One-sample with SNPs from external GWAS","Healthy","Europeans","not discussed","Illumina HumanHap 370k/670k and Illumina Cardio-Metabochip and iPLEX Sequenom MassARRAY (multiple cohorts)","not discussed","To assess the potential pleiotropic role of each genetic variant, we tested the effect of omitting each variant from the gene score by calculating the correspondence between cross-sectional associations and causal effect estimates","not discussed","Not discussed","Yes","Not discussed",NA,NA,"32","32",NA,"Not discussed",NA,"Two-stage-least-squares",NA,NA,NA,NA,NA,"Not discussed","F-statistic = 194","Not discussed","Not discussed","No","No","Bonferroni (100 tests)","1kg/m2","SD","beta","1.12",NA,"95","0.527","1.7","2.0000000000000001E-4","Not discussed","Not discussed","GRS associated with BMI in individual data, metabolites require more power (sex differences apparent), larger breadth of metabolites from different platforms may help","Results were consistent when each individual variant was omitted in turn from the gene score (Table 2), suggesting that the metabolic effects are not attributable to a specific genetic variant.","Not discussed","No post-hoc test, but some metabolites require more power",NA,1996
